Pregnancy Test Kits Global Market Report 2024

The pregnancy test kits market size has grown strongly in recent years. It will grow from $1.7 billion in 2023 to $1.8 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the development of early pregnancy tests, increased awareness of women's health, educational campaigns, global population growth, the convenience of home testing, and the rise of e-commerce.

The pregnancy test kits market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to rising fertility awareness, market expansion in developing countries, regulatory support for home testing kits, adoption of telehealth, and customization and personalization. Major trends in the forecast period include digital pregnancy tests, home-based and self-testing options, integration of smartphone technology, integration of artificial intelligence, and point-of-care testing.

The market for pregnancy test kits is anticipated to witness growth due to an escalation in unplanned pregnancies. Unplanned pregnancies, encompassing unwanted or unforeseen conceptions, are driving the demand for pregnancy test kits. These kits, designed to confirm pregnancy, play a pivotal role in determining a woman's pregnancy status, irrespective of the intention behind it. For example, data from March 2022, sourced from the United Nations Population Fund, highlights a global annual incidence of 121 million unintended pregnancies. Moreover, projections for Afghanistan estimate a rise to 4.8 million unintended pregnancies by 2025. Thus, the surge in unplanned pregnancies is poised to fuel the pregnancy test kits market.

A notable challenge impeding the pregnancy test kits market growth stems from the lack of adequate knowledge among women about these testing tools. Insufficient awareness about the availability and proper utilization of these kits could lead women to rely on subjective pregnancy signs, potentially causing delayed detection. This delay might impact prenatal care-seeking behaviors and, consequently, the health of both the expecting mother and the fetus. For instance, findings from November 2021, sourced from the National Library of Medicine, reported a 22% prevalence of pregnancy self-testing in western Kenya. Reasons for non-use included perceptions of unnecessary testing (58%), limited knowledge about self-tests (26%), and financial constraints (11%). Consequently, inadequate knowledge impedes the growth prospects of the pregnancy test kit market.

The projected expansion of the pregnancy test kits market is anticipated due to an upsurge in fertility rates. Fertility rates denote the average number of children a woman might have during her reproductive years. Pregnancy test kits play a crucial role in confirming pregnancy, especially for women aiming to conceive. A positive result indicates successful fertilization and fertility. Data from August 2022, sourced from the UK's Office for National Statistics, illustrates a 1.9% rise in England's total fertility rate (TFR), climbing from 1.59 children per woman in 2020 to 1.62 children per woman in 2021. Hence, the burgeoning fertility rate is a key driver propelling the growth of the pregnancy test kits market.

Innovative product development, exemplified by at-home test kits such as PregaScreen, is a strategic move by leading companies aiming to augment their market share in the pregnancy test kits industry. PregaScreen, an at-home pregnancy test kit introduced by Mylab Discovery Solutions Pvt. Ltd., detects human chorionic gonadotropin (hCG) in urine accurately when used correctly. In June 2022, Mylab Discovery Solutions Pvt. Ltd. launched PregaScreen, ensuring women can independently determine their pregnancy status with precise results in minutes, boasting an impressive 99.99% accuracy rate. Each kit comprises a pregnancy stick and a dropper, providing a convenient testing solution for women seeking to confirm pregnancy after a missed menstrual period.

In October 2021, Everly Health Inc., a prominent provider of at-home health testing solutions based in the US, acquired Natalist for an undisclosed sum. This acquisition aligns with Everly's strategic objectives to bolster its status as a premier digital health company by integrating fertility and pregnancy essentials into its existing array of women's health products. Natalist, the acquired company, specializes in the production of pregnancy test kits in the United States.

Major companies operating in the pregnancy test kits market report are Johnson & Johnson, Procter & Gamble Co., Abbott Laboratories, Church & Dwight Co Inc, BioMerieux SA, Alere Inc, Piramal Enterprises Ltd, Quidel Corporation, Mankind Pharma, Cardinal Health Inc., Healthpoint, EKF Diagnostics Holdings PLC, Sugentech Inc, Egens Group, INTEC Group, Medsource Ozone Biomedicals, SPD Swiss Precision Diagnostics, Geratherm Medical AG, Princeton BioMeditech Corporation, Cupid Limited, Easy Healthcare Corporation, Axis Medicare Ltd., Gregory Pharmaceutical Holdings Inc, AccuQuik Test Kits, Sara Health Care Pvt Ltd., Hicks Thermometers India Limited, Fairhaven Health LLC, Atlas Medical Group, Germaine Laboratories Inc.

North America was the largest region in the pregnancy test kits market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnancy test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the pregnancy test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pregnancy test kits market consists of sales of kits such as test cassette format, test strip format, and test midstream format kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The primary categories of pregnancy test kits include blood tests for HCG and urine tests for HCG. Blood tests for HCG involve clinical assessments to measure the concentration of the human chorionic gonadotropin (HCG) hormone in the bloodstream. These kits are distributed through retail and online channels, catering to various settings such as hospitals, clinics, households, and pharmacies. The end users include both professionals and individuals using the kits at home.

The pregnancy test kits market research report is one of a series of new reports that provides pregnancy test kits market statistics, including pregnancy test kits industry global market size, regional shares, competitors with a pregnancy test kits market share, detailed pregnancy test kits market segments, market trends and opportunities, and any further data you may need to thrive in the pregnancy test kits industry. This pregnancy test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.